Oxeia Biopharmaceuticals, Inc. is a clinical stage biotech company developing drug treatments for concussions and acute neurotrauma. Rest is not enough!
Location: United States, Massachusetts, Boston
Investors 1
| Date | Name | Website |
| - | Tech Coast... | techcoasta... |
Mentions in press and media 5
| Date | Title | Description |
| 23.06.2026 | US Navy Rear Admiral Don Plummer Joins Oxeia Biopharma Advisory Board as Military Concussions Remain Critical Challenge | Former Navy SEAL to Help Advance Awareness of Military Brain Injuries and the Need for Effective Concussion Treatment BOSTON, MA, UNITED STATES, June 23, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals, a clinical-stage biotech company ... |
| 11.06.2026 | NFL’s ALEX SMITH JOINS OXEIA INVESTOR WEBINAR EXPLORING WHAT COULD BECOME THE FIRST FDA-APPROVED CONCUSSION THERAPY | Live June 18 Event Gives Investors Access to a Potential Breakthrough in Brain Injury Treatment BOSTON, MA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals will host a live investor webinar on June 18, 2026, from... |
| 15.05.2026 | OXEIA BIOPHARMACEUTICALS NAMED MOST INNOVATIVE mTBI COMPANY 2026 | Second Year Running Oxeia is Recognized for its Concussion Drug, OXE103; Award Honors Excellence, Resilience and Innovation BOSTON, MA, UNITED STATES, May 15, 2026 /EINPresswire.com/ -- Global Health & Pharma announced today that Oxeia ... |
| 08.04.2026 | Oxeia Biopharmaceuticals Oversubscribes First Crowdfunding Campaign, Extends Round for New Investors | Concussion therapeutics developer surpasses crowdfunding goal reflecting strong investor interest in its clinical-stage ghrelin therapy for persistent symptoms. BOSTON, MA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Oxeia Biopharmac... |
| - | Oxeia Biopharmaceuticals | “Oxeia Biopharmaceuticals” |